Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
What's New and True for Treatment of Port Wine Birthmarks
Description
The discussion focuses on the latest findings in the treatment of port wine birthmarks (PWBs), emphasizing the genetic underpinnings that contribute to their formation. The primary causative factors include activating variants in genes such as GNAQR and GNA11, which are implicated in approximately 95% of cases. Understanding the genetics is crucial, as it aids in identifying potential therapeutic targets informed by oncology research. The talk also outlines the clinical challenges of managing these birthmarks and the necessity for early intervention to optimize treatment outcomes. Advances in optical coherence tomography (OCT) are highlighted, illustrating its efficacy in mapping the vascular characteristics of PWBs and improving diagnostic accuracy. Another focus is on the variability in responses to treatments due to the heterogeneous nature of these birthmarks, which is affected by the distribution of mutant cells. Current therapies include pulsed-dye laser treatments, but challenges remain due to incomplete elimination of the underlying vascular anomalies. Future directions point toward developing targeted medications that can address specific molecular pathways. Continued research is needed to refine treatment protocols and potentially adopt lifelong therapeutic strategies for individuals affected by PWBs.
View moreConclusions
- Mosaic variants in genes regulating cell growth and proliferation are the primary cause of port wine birthmarks, particularly involving GNAQ.
- Understanding the mosaic nature of these variants is crucial since most are not present in blood samples.
- There is significant variability in clinical responses to treatment within individuals, even with the same genetic makeup.
- Early intervention in infants shows better outcomes for treatment of port wine birthmarks.
- Optical coherence tomography (OCT) can be used to visualize and measure blood vessel characteristics in PWB, revealing significant heterogeneity.
- Higher vessel density is observed at shallower depths (0.15-0.2 mm) in affected areas compared to controls, but deeper layers show varied results depending on the lesion type.
- Hypertrophic lesions exhibit increased vessel density at greater depths compared to flat lesions, indicating tailored approaches to treatment may be necessary.
- OCT may help differentiate between high and low flow lesions based on vessel diameter and density but can vary by age and lesion location.
- Treatment success is correlated with vessel size; smaller diameter vessels tend to respond better to therapy than larger vessels.
- Targeted therapies addressing specific molecular pathways associated with GNAQ mutations represent a promising future direction for port wine birthmark treatments.
- Trigt W et al, Front Hum Neurosci. 03 Nov 2022; 16:2006027.
- Greene AK, Goss JA. Plast Reconstr Surg. 2018 May;141(5):709e-717e.
- Davies OMT, et al. Pediatr Dermatol. 2022;39:914-919; Shirley MD, et al. N Engl J Med. 2013;368:1971-1979; Huang L, et al. Arterioscler Thromb Vasc Biol. 2022;42:e27-43.
- Schrenk et al, Nat Commun. 2023 Apr 6;14(1):1929.
- Wisinski et al, JCO Precis Oncol. 2023;7.
- Carvajal et al, J Clin Oncol 2018 Apr 20;36(12).